Design
Review
Key result
Nanoparticle-based drug delivery systems targeting inflammatory immune mechanisms show potential in controlling excessive inflammation and supporting tissue repair after acute myocardial infarction.
Authors
Loading...
Hypothesis-generating for nanoparticle therapies post-AMI; prospective trials needed before any clinical consideration.
Nanoparticle-based drug delivery systems offer a promising approach to modulate the post-AMI inflammatory response, though challenges in targeting precision and scalability remain.
Li et al. (2025) conducted a review in Acute myocardial infarction. Nanoparticle-based drug delivery systems was evaluated. Nanoparticle-based drug delivery systems targeting inflammatory immune mechanisms show potential in controlling excessive inflammation and supporting tissue repair after acute myocardial infarction.